Advertisement
CVRX vs TMCI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVRX is a Hold and TMCI is a StrongBuy.
CVRX's Indicator enters downward trend
The Aroon Indicator for CVRX entered a downward trend on October 21, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 202 similar instances where the Aroon Indicator formed such a pattern. In 176 of the 202 cases the stock moved lower. This puts the odds of a downward move at 87%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CVRX as a result. In 58 of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for CVRX just turned positive on October 20, 2026. Looking at past instances where CVRX's MACD turned positive, the stock continued to rise in 42 of 47 cases over the following month. The odds of a continued upward trend are 89%.
Following a +6.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where CVRX advanced for three days, in 247 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
CVRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.829) is normal, around the industry mean (2.923). P/E Ratio (-0.695) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.292) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. CVRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
TMCI in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 06, 2026
TMCI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 38 of 44 cases where TMCI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TMCI's RSI Oscillator exited the oversold zone, 33 of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 59 cases where TMCI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on TMCI as a result. In 69 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for TMCI just turned positive on October 21, 2026. Looking at past instances where TMCI's MACD turned positive, the stock continued to rise in 31 of 43 cases over the following month. The odds of a continued upward trend are 72%.
Following a +6.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where TMCI advanced for three days, in 205 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Bearish Trend Analysis
TMCI moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TMCI crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMCI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for TMCI entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.975) is normal, around the industry mean (2.923). P/E Ratio (-4.500) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.430) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 36 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. TMCI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TMCI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
| CVRX | TMCI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 85% | 2 days ago 77% |
| Stochastic ODDS (%) | 2 days ago 76% | 2 days ago 69% |
| Momentum ODDS (%) | 2 days ago 79% | 2 days ago 76% |
| MACD ODDS (%) | 2 days ago 89% | 2 days ago 72% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 77% |
| TrendMonth ODDS (%) | 2 days ago 88% | 2 days ago 86% |
| Advances ODDS (%) | 3 days ago 83% | 2 days ago 76% |
| Declines ODDS (%) | 9 days ago 87% | 15 days ago 86% |
| BollingerBands ODDS (%) | 2 days ago 84% | 2 days ago 86% |
| Aroon ODDS (%) | 2 days ago 87% | 2 days ago 89% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CVRX’s FA Score shows that 1 FA rating(s) are green while TMCI’s FA Score has 1 green FA rating(s).
- CVRX’s FA Score: 1 green, 4 red.
- TMCI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CVRX’s TA Score shows that 5 TA indicator(s) are bullish while TMCI’s TA Score has 6 bullish TA indicator(s).
- CVRX’s TA Score: 5 bullish, 3 bearish.
- TMCI’s TA Score: 6 bullish, 4 bearish.
Price Growth
CVRX (@Medical/Nursing Services) experienced а +2.24% price change this week, while TMCI (@Medical/Nursing Services) price change was +2.48% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.52%. For the same industry, the average monthly price growth was -10.68%, and the average quarterly price growth was -10.35%.
Reported Earning Dates
CVRX is expected to report earnings on Nov 04, 2026.
TMCI is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Medical/Nursing Services (-1.52% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
CVRX and
Correlation & Price change
A.I.dvisor indicates that over the last year, CVRX has been closely correlated with STRRP. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if CVRX jumps, then STRRP could also see price increases.
| Ticker / NAME | Correlation To CVRX | 1D Price Change % | ||
|---|---|---|---|---|
| CVRX | 100% | -1.44% | ||
| STRRP - CVRX | 67% Closely correlated | -2.43% | ||
| AZTA - CVRX | 39% Loosely correlated | +2.88% | ||
| TMCI - CVRX | 34% Loosely correlated | +1.72% | ||
| A - CVRX | 34% Loosely correlated | +2.74% | ||
| ATRC - CVRX | 32% Poorly correlated | N/A | ||
More | ||||
TMCI and
Correlation & Price change
A.I.dvisor indicates that over the last year, TMCI has been loosely correlated with UTMD. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if TMCI jumps, then UTMD could also see price increases.
| Ticker / NAME | Correlation To TMCI | 1D Price Change % | ||
|---|---|---|---|---|
| TMCI | 100% | +1.72% | ||
| UTMD - TMCI | 48% Loosely correlated | -0.47% | ||
| GMED - TMCI | 45% Loosely correlated | -0.35% | ||
| CRL - TMCI | 39% Loosely correlated | +9.33% | ||
| AZTA - TMCI | 39% Loosely correlated | +2.88% | ||
| MTD - TMCI | 39% Loosely correlated | +2.69% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EWT | 108.99 | 1.66 | +1.55% |
| iShares MSCI Taiwan ETF (EWT) | |||
| MSFL | 28.16 | 0.11 | +0.38% |
| GraniteShares 2x Long MSFT Daily ETF (MSFL) | |||
| MBBA | 47.47 | 0.03 | +0.06% |
| iShares Mortgage-Backed Securities Active ETF (MBBA) | |||
| IDVZ | 33.86 | 0.01 | +0.03% |
| Opal International Dividend Income ETF (IDVZ) | |||
| EBIT | 38.44 | -0.08 | -0.21% |
| Harbor Small Cap Earners ETF (EBIT) | |||